A study of relacorilant in combination with nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)
Borazanci et al • 2022 • American Society of Clinical Oncology Annual Meeting
© 2024 Corcept Therapeutics, Incorporated
DAZALS: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis
Mann et al • 2022 • European Network to Cure ALS (ENCALS)
Favorable liver safety profile of the selective glucocorticoid receptor modulator relacorilant in healthy and hepatically impaired adults and in patients with cushing syndrome
Moritis et al • 2022 • European Congress of Endocrinology
Mifepristone Use in Hypercortisolism from an Unknown Source: A Case Study
Brown et al • 2022 • American Association of Clinical Endocrinology (AACE) Annual Meeting